The event, which will take place February 6-8 in Seattle, will cover important issues and controversies in the omega-3 market.
Amarin’s Vascepa Omega-3 Drug Aims to Eliminate Dietary Supplement Competition with International Trade Commission Complaint, CRN Says
Amarin’s ITC complaint alleges that synthetically produced omega-3 products that are predominantly composed of EPA in either ethyl ester or re-esterified form are not considered “dietary ingredients” under Section 201(ff)(1) of the Federal Food Drug and Cosmetic Act, and thus, are not legal dietary supplements but unapproved new drugs.
The meta-analysis, comprising 14 randomized, controlled trials featuring 71,899 subjects, found that omega-3s EPA and DHA supplementation may reduce the risk of cardiac death by 8%, and that benefits may be even greater for subjects with elevated triglycerides or LDL cholesterol.
Neptune will quit its bulk krill oil manufacturing and distribution business, with remaining krill oil inventory and IP transferring to Aker BioMarine.
The company says that its new K-Real Gold krill oil features greater levels of highly concentrated omega-3s and astaxanthin and is free of TMAO and TMA.
This standard is the first Codex Alimentarius standard for fish oil as well as krill oil.
Algae address today’s demands for plant-based, sustainable ingredients.
According to the company, the agreement is expected to triple Qualitas’s production, helping it achieve a “critical mass to become a sustainable omega-3 alternative at commercial scale.”
GOED discusses how our understanding of omega-3's role in human health has evolved over time.
Researchers found that most fish oil products on the market in New Zealand do meet regulatory limits for oxidation and label claims about EPA and DHA content.